NADPH oxidase

gene

NOX-mediated ROS production drives endothelial activation and inflammatory cell recruitment; its inhibition supports endothelial progenitor repair.

Pathway placement

Cascade stepPlaque inflammation

Confidencemedium

RationaleReactive oxygen generation; endothelial dysfunction and inflammation.

Also acts inEndothelial activation/erosion

Druggability

Not assessed (no mapped human gene target).

Type I vs Type II discrimination

ScoresShared / rises in both

R — rupture / Type-I

C — confounder / Type-II

A — assay feasibility

E — evidence strength

T1DI (composite)

Specificity differential (R−C)-14

Confounder panel (Type-II drivers)

1sepsis / systemic inflammationmag 3

2anemia / acute blood lossmag 2

3hypovolemia / dehydrationmag 2

4tachyarrhythmiamag 3

5hypoxemia / respiratory failuremag 2

6hypertensive emergencymag 3

7high-demand / peri-operative stressmag 2

Coverage: 7/7 confounders with evidence

Tier: deep-scored (abstract-extracted) · 23 supporting references. See the discrimination table for all markers.

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.

Specimen

Whole blood — gene is not a circulating analyte; measure protein product or genotype

Collection tube

K2-EDTA whole blood (lavender-top)

Method / principle

SNP genotyping / sequencing; or immunoassay of encoded protein

Reagent / substrate

Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein

Platform

qPCR / NGS / array

Turnaround · availability

Send-out · Genotyping widely available; protein assay variable